A recall has been issued for blood pressure medicine used in New York. It could cause harm or death to patients. Par Pharmaceutical has issued a recall for its blood pressure medicine, according to the Food and Drug Administration. The medicine is contaminated with silicon particles. it was sold in New York and nationwide and distributed to wholesalers and hospitals between June 2022 and August 2023. Seven lots of Treprostinil for injection are at the center of the recall due to possible contamination of silicon particles in the solution.